Symptom Improvements in Gastroesophageal Reflux Disease (GERD) Patients

Clinical trial NCT00394472 · COMPLETED

Trial details

NCT number: NCT00394472
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gastroesophageal Reflux Disease (GERD)

Start date: 2006-11-01
Primary completion: 2007-06-01
Enrollment: 244

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.